Synthetic peptide conjugated to KLH, corresponding to a region within internal sequence amino acids 270-300 of Human HSD17B2
- MDA-MB435 cell line lysates, Human prostate carcinoma
Shipped at 4°C. Store at 4°C (up to 6 months). Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Immunogen affinity purified
This antibody is purified through a protein A column, followed by peptide affinity purification.
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||1/50 - 1/100. Predicted molecular weight: 43 kDa.
||1/100 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3 uses NADPH.
Belongs to the short-chain dehydrogenases/reductases (SDR) family.
Information by UniProt
- 17 beta HSD 2 antibody
- 17-beta-HSD 2 antibody
- 17-beta-hydroxysteroid dehydrogenase type 2 antibody
Western blot - HSD17B2 antibody (ab103665)
Anti-HSD17B2 antibody (ab103665) at 1/100 dilution + MDA-MB435 cell line lysates at 35 µg
Predicted band size: 43 kDa
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HSD17B2 antibody (ab103665)
IHC analysis of HSD17B2 expression in formalin fixed and paraffin embedded Human prostate carcinoma using 1/50 ab103665 followed by peroxidase conjugation of the secondary antibody and DAB staining.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"